These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 27207553
1. A Novel Function of Hepatic FOG2 in Insulin Sensitivity and Lipid Metabolism Through PPARα. Guo Y, Yu J, Deng J, Liu B, Xiao Y, Li K, Xiao F, Yuan F, Liu Y, Chen S, Guo F. Diabetes; 2016 Aug; 65(8):2151-63. PubMed ID: 27207553 [Abstract] [Full Text] [Related]
2. Mouse KLF11 regulates hepatic lipid metabolism. Zhang H, Chen Q, Yang M, Zhu B, Cui Y, Xue Y, Gong N, Cui A, Wang M, Shen L, Zhang S, Fang F, Chang Y. J Hepatol; 2013 Apr; 58(4):763-70. PubMed ID: 23183531 [Abstract] [Full Text] [Related]
3. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin. Sugden MC, Bulmer K, Gibbons GF, Knight BL, Holness MJ. Biochem J; 2002 Jun 01; 364(Pt 2):361-8. PubMed ID: 12023878 [Abstract] [Full Text] [Related]
4. Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4. Sanguino E, Roglans N, Alegret M, Sánchez RM, Vázquez-Carrera M, Laguna JC. Br J Pharmacol; 2005 Aug 01; 145(7):853-61. PubMed ID: 15912134 [Abstract] [Full Text] [Related]
5. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice. Zhu LH, Wang A, Luo P, Wang X, Jiang DS, Deng W, Zhang X, Wang T, Liu Y, Gao L, Zhang S, Zhang X, Zhang J, Li H. J Hepatol; 2014 May 01; 60(5):1046-54. PubMed ID: 24445216 [Abstract] [Full Text] [Related]
6. Lemon Balm Extract ALS-L1023 Regulates Obesity and Improves Insulin Sensitivity via Activation of Hepatic PPARα in High-Fat Diet-Fed Obese C57BL/6J Mice. Lee D, Shin Y, Roh JS, Ahn J, Jeoong S, Shin SS, Yoon M. Int J Mol Sci; 2020 Jun 15; 21(12):. PubMed ID: 32549364 [Abstract] [Full Text] [Related]
7. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism. Ljungberg A, Lindén D, Améen C, Bergström G, Oscarsson J. Growth Horm IGF Res; 2007 Apr 15; 17(2):154-64. PubMed ID: 17307376 [Abstract] [Full Text] [Related]
8. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R. Obesity (Silver Spring); 2010 Apr 15; 18(4):780-7. PubMed ID: 19798065 [Abstract] [Full Text] [Related]
9. Endoplasmic reticulum stress induces hepatic steatosis through interaction between PPARα and FoxO6 in vivo and in vitro. Kim DH. J Mol Med (Berl); 2024 Oct 15; 102(10):1267-1284. PubMed ID: 39198274 [Abstract] [Full Text] [Related]
11. Long non-coding RNA G23Rik attenuates fasting-induced lipid accumulation in mouse liver. Kim D, Kim B, Brocker CN, Karri K, Waxman DJ, Gonzalez FJ. Mol Cell Endocrinol; 2022 Nov 01; 557():111722. PubMed ID: 35917881 [Abstract] [Full Text] [Related]
12. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways. Zhang H, Shen WJ, Cortez Y, Kraemer FB, Azhar S. Am J Physiol Gastrointest Liver Physiol; 2013 Jan 01; 304(1):G72-86. PubMed ID: 23104557 [Abstract] [Full Text] [Related]
13. Liver-specific knockdown of long-chain acyl-CoA synthetase 4 reveals its key role in VLDL-TG metabolism and phospholipid synthesis in mice fed a high-fat diet. Singh AB, Kan CFK, Kraemer FB, Sobel RA, Liu J. Am J Physiol Endocrinol Metab; 2019 May 01; 316(5):E880-E894. PubMed ID: 30721098 [Abstract] [Full Text] [Related]
14. Astragalus polysaccharides affect insulin resistance by regulating the hepatic SIRT1-PGC-1α/PPARα-FGF21 signaling pathway in male Sprague Dawley rats undergoing catch-up growth. Gu C, Zeng Y, Tang Z, Wang C, He Y, Feng X, Zhou L. Mol Med Rep; 2015 Nov 01; 12(5):6451-60. PubMed ID: 26323321 [Abstract] [Full Text] [Related]
16. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T, Turk J, Semenkovich CF. Cell Metab; 2005 May 01; 1(5):309-22. PubMed ID: 16054078 [Abstract] [Full Text] [Related]
17. Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation. Regué L, Minichiello L, Avruch J, Dai N. J Biol Chem; 2019 Aug 02; 294(31):11944-11951. PubMed ID: 31209109 [Abstract] [Full Text] [Related]
18. Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation. McCarthy TC, Pollak PT, Hanniman EA, Sinal CJ. J Pharmacol Exp Ther; 2004 Dec 02; 311(3):864-73. PubMed ID: 15265979 [Abstract] [Full Text] [Related]
19. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice. Ide T, Tsunoda M, Mochizuki T, Murakami K. Med Sci Monit; 2004 Oct 02; 10(10):BR388-95. PubMed ID: 15448592 [Abstract] [Full Text] [Related]
20. Over-expression of PPARα in obese mice adipose tissue improves insulin sensitivity. Takahashi H, Sanada K, Nagai H, Li Y, Aoki Y, Ara T, Seno S, Matsuda H, Yu R, Kawada T, Goto T. Biochem Biophys Res Commun; 2017 Nov 04; 493(1):108-114. PubMed ID: 28919422 [Abstract] [Full Text] [Related] Page: [Next] [New Search]